In this episode, Founder, President & Chief Executive Officer of Annovis Dr. Maria Maccecchini discusses the biological difficulties of treating cognitive diseases like Alzheimer’s, Parkinson’s and Dementia, and how two developing therapeutics may hold the key to stopping them.
You should have Maria on again when she reports on the interim data of her Phase 3 trials in Parkinson’s and Alzheimer’s. People will want to see the success and progress.
Thanks for your feedback. We definitely will be tracking with Maria and the company regarding these promising outcomes. She is welcome on the show anytime. Thanks for listening and your support.